Skip to content
10-Q

Quarterly Report

ANTIVIRAL TECHNOLOGIES, INC.

0001137050-12-000289

← back to feed
Filed
Aug 14, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2012 · Jun 30, 2012 150M sh
Operating Cash Flow Q2 2012 · Jun 30, 2012 −$1.1M
Operating Cash Flow Q2 2012 · Jun 30, 2011 −$71.96K
Stockholders Equity Q2 2012 · Jun 30, 2012 −$2.11M
Stockholders Equity Q2 2012 · Dec 31, 2011 −$1.93M
Total Liabilities Q2 2012 · Jun 30, 2012 $2.58M
Total Liabilities Q2 2012 · Dec 31, 2011 $2.34M
Current Assets Q2 2012 · Jun 30, 2012 $489
Current Assets Q2 2012 · Dec 31, 2011 $4.88K
Total Assets Q2 2012 · Jun 30, 2012 $472.93K
Total Assets Q2 2012 · Dec 31, 2011 $405.56K
Sga Expense Q2 2012 · Jun 30, 2012 $1.94M
Sga Expense Q2 2012 · Jun 30, 2011 $87.67K
Sga Expense Q2 2012 · Jun 30, 2011 $181.78K
Net Income Q2 2012 · Jun 30, 2012 −$2.11M
Net Income Q2 2012 · Jun 30, 2011 −$87.67K
Net Income Q2 2012 · Jun 30, 2011 −$183.46K
Cash And Equivalents Q2 2012 · Dec 31, 2010 $3.13K